In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
woman with shaved head in mirror
How to Regain Body Confidence after Cancer

Hear from an MSK social worker about developing body confidence after cancer treatment.
MSK surgeons are highly skilled at treating even the most difficult gynecologic cancers.
In the Clinic
5 Reasons MSK Excels at Treating Gynecologic Cancers

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.
Memorial Sloan Kettering Among the Top “Best Hospitals” for Cancer Care and Ranked First in Gynecology by U.S News & World Report

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to <i>U.S. News & World Report</i> in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.
Cracking a Code: Landmark Prospective Study Helps Researchers Better Understand Which MGUS Patients Will Progress to a Multiple Myeloma Diagnosis

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in <i>JAMA Oncology</i>.
Green and blue blobs on a black background
In the Lab
Researchers Discover How T Cells Cause Post-Transplant Damage

Innovative imaging techniques shed light on intestinal damage that occurs after bone marrow transplant.
Doctor and patient
In the Clinic
Study Asks: Are Women Missing Out on BRCA Testing?

Results from a study of women with breast and ovarian cancer show surprisingly low rates of genetic testing.
Thomas Fuchs
In the Lab
Researchers Report Milestone in Use of Artificial Intelligence in Pathology

MSK researchers developed an artificial intelligence system to detect cancer on digitized microscope slides.
Computational biologist Barry Taylor
Finding
Whether a BRCA Mutation Leads to Cancer Depends on Context, Study Finds

Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development.
Old man lying in hospital bed being spoken to by nurse
Q&A
Keeping Patients out of the Hospital: MSK Geriatrics Specialist Explains the Keys to Caring for Older People with Cancer

An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.
George Bosl
Announcement
Respected Physician and Researcher George J. Bosl Named Memorial Sloan Kettering's First Ombudsperson, a Confidential Resource for Staff

Learn about George Bosl, who will become MSK's first ombudsperson.